Supernus Pharmaceuticals, Inc. (SUPN) — DEF 14A Filings
All DEF 14A filings from Supernus Pharmaceuticals, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Supernus Pharma Files Proxy Statement
— Apr 30, 2025 Risk: low
Supernus Pharmaceuticals, Inc. filed its definitive proxy statement on April 30, 2025, for its annual meeting on June 16, 2025. The filing outlines the company' -
Supernus Pharmaceuticals Announces 2024 Annual Meeting of Stockholders
— Apr 29, 2024 Risk: low
SUPERNUS PHARMACEUTICALS, INC. (SUPN) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. The 2024 Annual Meeting of Stockholders for Supernus Pha
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX